Latest immunotherapy Stories
STALLERGENES exercised option to pursue the exclusive development of application of ActoGeniX's technology for targeted delivery of allergen-based treatments ANTONY, France and GHENT,
Internationally renowned cancer genetics expert to take the helm in the new year SEATTLE, Nov.
Another Active Immunotherapy Product Added to Inovio's Growing Cancer R&D Pipeline PLYMOUTH MEETING, Pa., Nov. 20, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., Nov. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
A few treatment options and tips for one dealing with lung cancer. (PRWEB) November 12, 2014 For such a serious medical condition, the symptoms warning
PLYMOUTH MEETING, Pa., Nov. 10, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
BETHESDA, Md., Nov. 7, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
Results presented in poster presentation beginning today and in oral presentation Saturday, November 8, at 1:40 PM at Society for Immunotherapy of Cancer annual meeting. ANN ARBOR,
GAITHERSBURG, Md., Nov. 7, 2014 /PRNewswire-iReach/ -- Panacea Pharmaceuticals, Inc.
MONMOUTH JUNCTION, N.J., Nov.
- An interdisciplinary study of social injustice.